Literature DB >> 1800662

Limiting and repairing the damage in multiple sclerosis.

A Compston.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1800662      PMCID: PMC1014611          DOI: 10.1136/jnnp.54.11.945

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  35 in total

Review 1.  The macroglial cells of the rat optic nerve.

Authors:  R H Miller; C Ffrench-Constant; M C Raff
Journal:  Annu Rev Neurosci       Date:  1989       Impact factor: 12.449

2.  Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.

Authors:  D R Wren; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Ultrastructural identification of HRP-injected oligodendrocytes in the intact rat optic nerve.

Authors:  B R Ransom; A M Butt; J A Black
Journal:  Glia       Date:  1991       Impact factor: 7.452

4.  The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.

Authors:  B G Weinshenker; B Bass; G P Rice; J Noseworthy; W Carriere; J Baskerville; G C Ebers
Journal:  Brain       Date:  1989-12       Impact factor: 13.501

5.  Extensive oligodendrocyte remyelination following injection of cultured central nervous system cells into demyelinating lesions in adult central nervous system.

Authors:  W F Blakemore; A J Crang
Journal:  Dev Neurosci       Date:  1988       Impact factor: 2.984

6.  Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.

Authors:  N J Scolding; B P Morgan; W A Houston; C Linington; A K Campbell; D A Compston
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

7.  Oligodendrocyte susceptibility to injury by T-cell perforin.

Authors:  N J Scolding; J Jones; D A Compston; B P Morgan
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

8.  Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord.

Authors:  R J Franklin; A J Crang; W F Blakemore
Journal:  J Neurocytol       Date:  1991-05

9.  Oligodendrocytes repel axons and cause axonal growth cone collapse.

Authors:  J W Fawcett; J Rokos; I Bakst
Journal:  J Cell Sci       Date:  1989-01       Impact factor: 5.285

10.  Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading.

Authors:  P Caroni; M E Schwab
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

View more
  7 in total

1.  Multiple sclerosis: diagnostic optimism.

Authors:  W I McDonald
Journal:  BMJ       Date:  1992-05-16

2.  The Homeodomain Transcription Factors Vax1 and Six6 Are Required for SCN Development and Function.

Authors:  Erica C Pandolfi; Joseph A Breuer; Viet Anh Nguyen Huu; Tulasi Talluri; Duong Nguyen; Jessica Sora Lee; Rachael Hu; Kapil Bharti; Dorota Skowronska-Krawczyk; Michael R Gorman; Pamela L Mellon; Hanne M Hoffmann
Journal:  Mol Neurobiol       Date:  2019-11-09       Impact factor: 5.590

3.  The dynamics of multiple sclerosis. The Charcot Lecture.

Authors:  W I McDonald
Journal:  J Neurol       Date:  1993-01       Impact factor: 4.849

4.  A placebo-controlled trial of isoprinosine in patients with multiple sclerosis.

Authors:  N M Milligan; D H Miller; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

5.  Optic neuritis and HIV-1 infection.

Authors:  B J Sweeney; H Manji; R J Gilson; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

Review 6.  Brain repair.

Authors:  A Compston
Journal:  J R Coll Physicians Lond       Date:  1994 Mar-Apr

Review 7.  The pathogenesis of multiple sclerosis. Additional considerations.

Authors:  C M Poser
Journal:  J Neurol Sci       Date:  1993-04       Impact factor: 3.181

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.